-
Company Chapter – Ilika – United Kingdom
Version: 2026-06-26, for paid subscribers
-
This chapter covers Ilika's Li-ion battery product development efforts and corresponding patent portfolio:
- The two product platforms – Goliath large-format cells for EVs and defence, and Stereax thin-film microbatteries for medical implants and IoT – and the distinct product development concepts spanning electrolyte chemistry, electrode architecture, and cell-manufacturing processes.
- An independent technology assessment covering the latest identified benchmarking data, unique-capability positioning, the core scientific leap of faith, technical approach and differentiation, timeline feasibility, scale-up risk factors, and the congruency between public statements and the underlying patent portfolio.
- Commercialization context including OEM and Tier-1 partnership timelines, contract-manufacturing and licensing strategy, manufacturing scale-up plans, and the validation gates that condition market entry.
-
Document size: ≈6,600 words, 21 images, 1 adjacent Excel file (list of patent families with AI-based summaries)
|
